Motor Vehicle Driving-Related Anxiety in Patients Undergoing Cardioverter Defibrillator Implantation and Cardiac Resynchronization Therapy With Defibrillators.
anxiety
cardiac resynchronization therapy
implantable cardioverter defibrillators
law
motor vehicle driving
Journal
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
revised:
18
08
2024
received:
17
05
2024
accepted:
12
09
2024
medline:
26
9
2024
pubmed:
26
9
2024
entrez:
26
9
2024
Statut:
ppublish
Résumé
Reducing anxiety about motor vehicle driving in patients receiving implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillators is important not only for improving quality of life but also for preventing vehicle collisions owing to driver distraction. This study aimed to clarify the driving-related anxiety of patients with these defibrillators and the factors that predict such anxiety. We conducted a cross-sectional survey using a self-administered questionnaire of patients who had been driving a vehicle after device implantation at a general hospital between August 2018 and November 2019. The mean age was 60.8 ± 12.6 years. The reasons for implantation were primary prevention in 47 patients and secondary prevention in 30 patients. A total of 16 patients experienced anxiety about driving and 61 did not. Significantly more younger patients (mean age of 50.4 vs. 63.6 years, p < 0.001) and those with implantable cardioverter defibrillators had anxiety (100% vs. 73.8%, p = 0.02). Multivariable analysis indicated that age was the only independent factor that predicted driving-related anxiety (odds ratio, 0.937; 95% confidence interval, 0.883-0.993). Identifying and addressing driving-related anxiety in patients (particularly young patients) with defibrillators is important in preventing motor vehicle collisions and improving quality of life.
Sections du résumé
BACKGROUND
BACKGROUND
Reducing anxiety about motor vehicle driving in patients receiving implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillators is important not only for improving quality of life but also for preventing vehicle collisions owing to driver distraction. This study aimed to clarify the driving-related anxiety of patients with these defibrillators and the factors that predict such anxiety.
METHODS
METHODS
We conducted a cross-sectional survey using a self-administered questionnaire of patients who had been driving a vehicle after device implantation at a general hospital between August 2018 and November 2019.
RESULTS
RESULTS
The mean age was 60.8 ± 12.6 years. The reasons for implantation were primary prevention in 47 patients and secondary prevention in 30 patients. A total of 16 patients experienced anxiety about driving and 61 did not. Significantly more younger patients (mean age of 50.4 vs. 63.6 years, p < 0.001) and those with implantable cardioverter defibrillators had anxiety (100% vs. 73.8%, p = 0.02). Multivariable analysis indicated that age was the only independent factor that predicted driving-related anxiety (odds ratio, 0.937; 95% confidence interval, 0.883-0.993).
CONCLUSIONS
CONCLUSIONS
Identifying and addressing driving-related anxiety in patients (particularly young patients) with defibrillators is important in preventing motor vehicle collisions and improving quality of life.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e70017Subventions
Organisme : Japanese Council of Traffic Science
Informations de copyright
© 2024 The Author(s). Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Références
Albrecht, J. S., A. L. Gruber‐Baldini, J. M. Hirshon, et al. 2014. “Hospital Discharge Instructions: Comprehension and Compliance Among Older Adults.” Journal of General Internal Medicine 29: 1491–1498.
Bardy, G. H., K. L. Lee, D. B. Mark, et al. 2005. “Sudden Cardiac Death in Heart Failure Trial Investigators. Amiodarone or an Implantable Cardioverter‐Defibrillator for Congestive Heart Failure.” New England Journal of Medicine 352: 225–237.
Bilge, A. K., B. Ozben, S. Demircan, et al. 2006. “Depression and Anxiety Status of Patients With Implantable Cardioverter Defibrillator and Precipitating Factors.” Pacing and Clinical Electrophysiology 29: 619–626.
Biscaglia, S., E. Tonet, R. Pavasini, et al. 2017. “A Counseling Program on Nuisance Bleeding Improves Quality of Life in Patients on Dual Antiplatelet Therapy: A Randomized Controlled Trial.” PLoS One 12, no. 8: e0182124.
Bjerre, J., S. H. Rosenkranz, A. M. Christensen, et al. 2018. “Driving Following Defibrillator Implantation: Development and Pilot Results From a Nationwide Questionnaire.” BioMed Central Cardiovascular Disorders 18: 212.
Bjerre, J., S. H. Rosenkranz, M. Schou, et al. 2021. “Driving Following Defibrillator Implantation: A Nationwide Register‐Linked Survey Study.” European Heart Journal 42, no. 35: 3529–3537.
Christopher, L. S., and J. M. Bostwick. 2005. “Implantable Cardioverter‐Defibrillators, Induced Anxiety, and Quality of Life.” Mayo Clinic Proceedings 80, no. 2: 232–237.
Connolly, S. J., A. P. Hallstrom, R. Cappato, et al. 2000. “Meta‐Analysis of the Implantable Cardioverter Defibrillator Secondary Prevention Trials. AVID, CASH and CIDS Studies.” European Heart Journal 21: 2071–2078.
Conti, J. B., D. A. Woodard, K. I. Tucker, et al. 1997. “Modification of Patient Driving Behavior After Implantation of a Cardioverter Defibrillator.” Pace 20: 2200–2204.
Cooper, D. K., R. M. Luceri, R. I. Thurer, et al. 1986. “The Impact of the Automatic Implantable Cardioverter Defibrillator on Quality of Life.” Pacing and Clinical Electrophysiology 4: 306–309.
Dubin, A. M., W. P. Batsford, R. J. Lewis, et al. 1996. “Quality‐Of‐Life in Patients Receiving Implantable Cardioverter Defibrillators at or Before Age 40.” Pacing and Clinical Electrophysiology 19, no. 11 Pt 1: 1555–1559.
Dunbar, S. B., C. D. Warner, and J. A. Purcell. 1993. “Internal Cardioverter Defibrillator Device Discharge: Experiences of Patients and Family Members.” Heart & Lung 22: 494–501.
Gopinathannair, R., D. R. Lerew, N. J. Cross, S. F. Sears, S. Brown, and B. Olshansky. 2017. “Longitudinal Changes in Quality of Life Following ICD Implant and the Impact of Age, Gender, and ICD Shocks: Observations From the INTRINSIC RV Trial.” Journal of Interventional Cardiac Electrophysiology 48, no. 3: 291–298.
Hitosugi, M., S. Gomei, T. Okubo, and S. Tokudome. 2012. “Sudden Illness While Driving a Vehicle: A Retrospective Analysis of Commercial Drivers in Japan.” Scandinavian Journal of Work, Environment & Health 38: 84–87.
Horwitz, L. I., J. P. Moriarty, C. Chen, et al. 2013. “Quality of Discharge Practices and Patient Understanding at an Academic Medical Center.” Journal of the American Medical Association Internal Medicine 173: 1715–1722.
Jespersen, C. H. B., J. Krøll, P. Bhardwaj, et al. 2023. “Severity of Brugada Syndrome Disease Manifestation and Risk of New‐Onset Depression or Anxiety: A Danish Nationwide Study.” Europace 25: 1–9.
Kobayashi, S., K. Nishimura, T. Suzuki, T. Shiga, and J. Ishigooka. 2014. “Post‐Traumatic Stress Disorder and Its Risk Factors in Japanese Patients Living With Implantable Cardioverter Defibrillators: A Preliminary Examination.” Journal of Arrhythmia 30: 105–110.
Kobza, R., F. Duru, and P. Erne. 2008. “Leisure‐Time Activities of Patients With ICDs: Findings of a Survey With Respect to Sports Activity, High Altitude Stays, and Driving Patterns.” Pacing and Clinical Electrophysiology 31, no. 7: 845–849.
Luderitz, B., W. Jung, A. Deister, et al. 1993. “The Quality of Life After the Implantation of a Cardioverter/Defibrillator in Malignant Arrhythmias.” Deutsche Medizinische Wochenschrift 118, no. 9: 285–289.
Miyazawa, K., Y. Kondo, M. Ueda, et al. 2018. “Prospective Survey of Implantable Defibrillator Shock Anxiety in Japanese Patients: Results From the DEF‐Chiba Study.” Pacing and Clinical Electrophysiology 41, no. 9: 1171–1177.
Moss, A. J., W. Zareba, W. J. Hall, et al. 2002. “Multicenter Automatic Defibrillator Implantation Trial Il Investigators. Prophylactic Implantation of a Defibrillator in Patients With Myocardial Infarction and Reduced Ejection Fraction.” New England Journal of Medicine 346: 877–883.
Oliva, A., J. Flores, S. Merigioli, et al. 2011. “Autopsy Investigation and Bayesian Approach to Coronary Artery Disease in Victims of Motor‐Vehicle Accidents.” Atherosclerosis 218: 28–32.
Pedersen, S. S., M. van den Berg, R. A. Erdman, et al. 2009. “Increased Anxiety in Partners of Patients With a Cardioverter‐Defibrillator: The Role of Indication for ICD Therapy, Shocks, and Personality.” Pacing and Clinical Electrophysiology 32: 184–192.
Pedersen, S. S., R. T. van Domburg, D. A. Theuns, et al. 2004. “Type D Personality Is Associated With Increased Anxiety and Depressive Symptoms in Patients With an Implantable Cardioverter Defibrillator and Their Partners.” Psychosomatic Medicine 66: 714–719.
Rahmawati, A., A. Chishaki, T. Ohkusa, et al. 2016. “Influence of Primary and Secondary Prevention Indications on Anxiety About the Implantable Cardioverter‐Defibrillator.” Journal of Arrhythmia 32, no. 2: 102–107.
Sears, S. F., J. L. Burns, E. Handberg, et al. 2001. “Young at Heart: Understanding the Unique Psychosocial Adjustment of Young Implantable Cardioverter Defibrillator Recipients.” Pacing and Clinical Electrophysiology 24: 1113–1117.
Sears, S. F., J. D. Hauf, K. Kirian, G. Hazelton, and J. B. Conti. 2011. “Posttraumatic Stress and the Implantable Cardioverter‐Defibrillator Patient: What the Electrophysiologist Needs to Know.” Circulation: Arrhythmia and Electrophysiology 4: 242–250.
Sears, S. F., J. F. Todaro, G. Urizar, et al. 2000. “Assessing the Psychosocial Impact of the ICD: A National Survey of Implantable Cardioverter Defibrillator Health Care Providers.” Pacing and Clinical Electrophysiology 23, no. 6: 939–945.
Shiga, T., T. Suzuki, and K. Nishimura. 2013. “Psychological Distress in Patients With an Implantable Cardioverter Defibrillator.” Journal of Arrhythmia 29: 310–313.
Statistics of Cardiac Implantable Electronic Devices (in Japanese), Japan Arrhythmia Device Industry Association. 2024. Tokyo, Japan: Japan Arrhythmia Device Industry Association. Accessed January 31, 2024. http://www.jadia.or.jp/accessed.
Suyama‐Chishaki, A., M. Miyazono, M. T. Makaya, et al. 2007. “Quality of Life and Psychological Factors in Patients With Implantable Cardioverter Defibrillator.” Journal of Arrhythmia 23: 269–276.
Suzuki, T., T. Shiga, K. Kuwahara, et al. 2010. “Prevalence and Persistence of Depression in Patients With Implantable Cardioverter Defibrillator: A 2‐Year Longitudinal Study.” Pacing and Clinical Electrophysiology 33: 1455–1461.
Tervo, T. M., W. Neira, A. Kivioja, et al. 2008. “Observational Failures/Distraction and Disease Attack/Incapacity as Cause(s) of Fatal Road Crashes in Finland.” Traffic Injury Prevention 9: 211–216.
Thylén, I., D. K. Moser, A. Strömberg, R. A. Dekker, and M. L. Chung. 2016. “Concerns About Implantable Cardioverter‐Defibrillator Shocks Mediate the Relationship Between Actual Shocks and Psychological Distress.” Europace 18, no. 6: 828–835.
Tomzik, J., K. C. Koltermann, M. Zabel, S. N. Willich, and T. Reinhold. 2015. “Quality of Life in Patients With an Implantable Cardioverter Defibrillator: A Systematic Review.” Frontiers in Cardiovascular Medicine 3, no. 2: 34.
Verkerk, A. J., A. M. Vermeer, E. M. Smets, et al. 2015. “Quality of Life in Young Adult Patients With a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.” Pacing and Clinical Electrophysiology 38, no. 7: 870–877.